- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02136472
Female Subfertility: a Metabolic and Vascular Profile
Female Subfertility: a First Sign of Metabolic and Cardiovascular Anomalies?
Introduction:
Overall, 10 - 15% of couples seek specialist help once in their lives when a spontaneous pregnancy does not occur. These couples are defined subfertile when there is at least one year of unprotected intercourse without conceiving. Subfertility can have different causes which can be diagnosed with a basic fertility work-up. Unfortunately, the subfertility in 25% of the couples still remains unexplained.
Hypothesis:
The investigators hypothesize that cardio-metabolic and hemodynamic abnormalities reducing cardiovascular reserves relate to circulatory redistribution at the expense of uterine perfusion and with it women's fertility. This could especially be important in the subgroups with an unexplained subfertility and a decreased ovarian reserve. Interventions to improve these abnormalities could lead to better results in fertility treatment, better obstetric outcome and reduced lifelong health risks.
Objective:
The investigators want to examine specific cardio-metabolic and cardiovascular parameters in women of subfertile couples. The investigators want to evaluate the prevalence of metabolic syndrome in all women who are assessed for subfertility compared to healthy parous women. Furthermore in the women with an unexplained subfertility or with (signs of) a decreased ovarian reserve the cardiovascular profile will be studied consisting of the uterine artery pulsatility index (PI) as measure of uterine perfusion, the plasma volume as measure of venous reserve capacity, the intima media thickness of the carotid arteries as proxy of chronic strain and the endothelial function, measured by flow mediated dilatation (FMD) of the brachial artery.
Study design:
Cross-sectional
Study population:
The study group consists of subfertile women between 18 and 41 years who visit the fertility clinic in the Maastricht University Medical Centre with a primary or secondary subfertility. Women with an unexplained subfertility or with (signs of) a decreased ovarian reserve are evaluated for their cardiovascular profile. The control group consists of women with a history of an uneventful spontaneous pregnancy.
Main study parameters:
- Prevalence of metabolic syndrome in subfertile women
The cardiovascular profile, in women with an unexplained subfertility or with (signs of) a decreased ovarian reserve, consisting of:
- The uterine artery pulsatility index
- The plasma volume
- The intima media thickness (IMT)
- The endothelial function of the vascular system (FMD)
Study Overview
Status
Conditions
Detailed Description
Introduction:
Overall, 10 - 15% of couples seek specialist help once in their lives when a spontaneous pregnancy does not occur. These couples are defined subfertile when there is at least one year of unprotected intercourse without conceiving. Subfertility can have different causes. A basic fertility work-up focuses on the reproductive system of the couple. After this basic fertility work-up the subfertility remains unexplained in 16-24% of the couples. The investigators hypothesize that cardio-metabolic and hemodynamic abnormalities reducing cardiovascular reserves relate to circulatory redistribution at the expense of uterine perfusion and with it women's fertility. This could especially be important in the subgroups with an unexplained subfertility and a decreased ovarian reserve. For all possible assessed abnormalities, proven effective treatments are available such as primarily life style corrective actions. Furthermore these interventions could lead to better results in fertility treatment, better obstetric outcome and reduced lifelong health risks.
Objective:
The overall objective of this study is to examine specific cardio-metabolic and cardiovascular parameters in women of subfertile couples. This study protocol is divided into 3 studies to evaluate several cardio-metabolic/cardiovascular parameters in different subgroups of female subfertility compared to fertile women.
- Study 1 "The metabolic syndrome and female subfertility": The prevalence of metabolic syndrome in all women who are assessed for subfertility compared to fertile women.
- Study 2 "The cardiovascular profile in female subfertility": The cardiovascular profile of women with female subfertility classified as unexplained subfertility or "expected" decreased ovarian reserve compared to fertile women. For this study 4 measurements will be performed: the uterine artery pulsatility index (PI) as measure of uterine perfusion, the plasma volume as measure of venous reserve capacity, the intima media thickness of the carotid arteries as proxy of chronic strain and the endothelial function, measured by flow mediated dilatation (FMD) of the brachial artery.
- Study 3 "The cardiovascular profile of women with a poor ovarian response": The cardiovascular profile of women who had an In Vitro Fertilisation (IVF) population with a "proven" decreased ovarian reserve
With these different studies, the investigators hope to identify possible cardio-metabolic/cardiovascular causes for female subfertility. This can lead to new treatment options for female subfertility, enhancing reproductive and obstetric outcome, and a risk assessment for later in life.
Study design:
We want to perform cross-sectional studies.
Study population:
Study 1:
- Study group: subfertile women between 18 and 41 years who visit the fertility clinic in the Maastricht University Medical Centre with a primary or secondary subfertility, independent of the cause of their subfertility
- Control group: women with a history of an uneventful spontaneous pregnancy
Study 2: Women who finished the basic fertility work up and are diagnosed with:
- an unexplained subfertility: study group 1
- an "expected" decreased ovarian reserve: study group 2 Control group: women with a history of an uneventful spontaneous pregnancy
Study 3: Women who received an IVF treatment in the period of 2010 - 2012 and:
- study group: had a "proven" decreased ovarian response, defined as retrieving 3 oocytes or less at an ovum pick-up, despite maximal ovarian stimulation
- control group: received and IVF/Intracytoplasmic Sperm Injection (ICSI) treatment because of a severe male subfertility
Main study parameters:
Study 1: Prevalence of metabolic syndrome in subfertile women compared to fertile controls.
Study 2: The cardiovascular profile, in women with an unexplained subfertility or an "expected" decreased ovarian reserve, consisting of:
- The uterine artery pulsatility index as measure for uterine perfusion
- The plasma volume as measure for venous reserve capacity
- The intima media thickness (IMT) of the carotid arteries as proxy for chronic strain
- The endothelial function of the vascular system (FMD)
Study 3: The cardiovascular profile, in women with a poor ovarian response, consisting of:
- The uterine artery pulsatility index as measure for uterine perfusion
- The plasma volume as measure for venous reserve capacity
- The intima media thickness (IMT) of the carotid arteries as proxy for chronic strain
- The endothelial function of the vascular system (FMD)
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Maastricht, Netherlands, 6229 HX
- Recruiting
- Maastricht University Medical Centre
-
Contact:
- Desiree APM Pattinaja
- Phone Number: 66370 +31433876543
- Email: desiree.pattinaja@mumc.nl
-
Sub-Investigator:
- Desiree Pattinaja, PhD candidate, MD
-
Principal Investigator:
- Ron van Golde, PhD, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Study 1:
- Study group: subfertile women between 18 and 41 years who visit our fertility clinic in the Maastricht University Medical Centre with a primary or secondary subfertility, independent of the cause of their subfertility
- Control group: women with a history of an uneventful spontaneous pregnancy
Study 2: Women who finished the basic fertility work up and are diagnosed with:
- an unexplained subfertility: study group 1
- an "expected" decreased ovarian reserve: study group 2 Control group: women with a history of an uneventful spontaneous pregnancy
Study 3: Women who received an IVF treatment in the period of 2010 - 2012 and:
- study group: had a "proven" decreased ovarian response, defined as retrieving 3 oocytes or less at an ovum pick-up, despite maximal ovarian stimulation
- control group: received and IVF/ICSI treatment because of a severe male subfertility
Description
Inclusion Criteria:
Study 1
Study group:
- primary subfertility, defined as having no previous pregnancy, or secondary subfertility, defined as a fertility problem after an ongoing pregnancy
- age 18 - 41 years
Control group:
- women with an uneventful pregnancy in history
- at least 6 months post partum
- age 18 - 41 years
Study 2
Study groups:
- primary subfertility, defined as having no previous pregnancy, or secondary subfertility, defined as a fertility problem after an ongoing pregnancy
- age 18 - 41 years
- participation in study 1
- no abnormalities in the basic fertility work up ("unexplained subfertility"); study group 1, or "expected" decreased ovarian reserve (Follicle Stimulating Hormone (FSH) > 8 u/l); study group 2
Control group:
- women with an uneventful pregnancy in history
- at least 6 months post partum
- age 18 - 41 years
Study 3
Study group:
- primary subfertility, defined as having no previous pregnancy, or secondary subfertility, defined as a fertility problem after an ongoing pregnancy
- age 18 - 40 years
- IVF / ICSI treatment in the period from 2010 - 2012
- proven decreased ovarian response (≤ 3 oocytes at an ovum-pick up)
- maximal stimulation dosage of 250 IU FSH per day
Control group:
- primary or secondary subfertility
- age 18 - 40 years
- IVF / ICSI treatment in the period from 2010 - 2012
- severe male factor (TMC < 3 million spermatozoa)
- retrieved ≥ 4 oocytes at an ovum-pick up
- normal stimulation dosage of 150 IU FSH per day
Exclusion Criteria:
Study 1
- There are no exclusion criteria for the study of the metabolic syndrome in the subfertile study group.
For the control group exclusion criteria are:
- current pregnancy
- hormonal medication
- breastfeeding
Study 2
For the studies of the measurement of the uterine artery PI, plasma volume, intima media thickness and endothelial function exclusion criteria in all women are:
- hypertension, defined as a blood pressure exceeding 140 mm Hg systolic or 90 mm Hg diastolic, or the use of antihypertensive medication
- diabetes mellitus, defined as a fasting glucose level above 6,1 mmol/L or the use of antidiabetic medication
Additional exclusion criteria for the control group:
- hormonal medication
- current pregnancy
- breastfeeding
Study 3
For the study group as well as the control group exclusion criteria are:
- extirpation of an ovary
- cystectomy
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
|---|
|
Subfertile women
Women who visit the fertility clinic of the Maastricht University Medical Centre who start with a basic fertility work-up. Women diagnosed with an unexplained subfertility or with (signs of) a decreased ovarian reserve are asked for further participation in the study of the cardiovascular profile. As a control group parous women with an uncomplicated pregnancy more than 6 months ago will be asked for participation. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The prevalence of the metabolic syndrome in subfertile women
Time Frame: Within 3 months of start of a basic fertility work-up
|
Subfertility is defined as trying to conceive for at least one year but did not lead to a pregnancy.
|
Within 3 months of start of a basic fertility work-up
|
|
The cardiovascular profile in subfertile women with an unexplained subfertility or a decreased ovarian reserve
Time Frame: Within 3 months after completing the basic fertility work-up
|
The cardiovascular profile consists of the plasma volume as measure of venous reserve, the uterine artery pulsatility index as measure of uterine perfusion, the intima media thickness as proxy of chronic strain and the endothelial function of the vascular system.
|
Within 3 months after completing the basic fertility work-up
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ron JT van Golde, MD, PhD, Maastricht University Medical Centre
- Study Director: Marc E Spaanderman, Prof, Maastricht University Medical Centre
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- METC 13-2-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Viable BiosciencesEnrolling by invitationInfertility (IVF Patients) | Infertility Assisted Reproductive TechnologyUnited States
-
Medipol UniversityNot yet recruitingMale Infertility | Unexplained Infertility | Sperm DNA Fragmentation